John Acquavella is a consultant in epidemiology and professor at Department of Clinical epidemiology, Aarhus University after more than 35 years of research and leadership positions in government, academia, and industry. He did his doctoral work in epidemiology at the Roswell Park Memorial Institute - State University of New York at Buffalo. SER awarded John the Lilienfeld student prize in 1989 for a paper based on his doctoral dissertation.
John has worked as an epidemiologist for the US Government (1978-81) and as an epidemiologist and department head for the University of California (1981-1983), Exxon-Mobil Corporation (1983-1989), Monsanto/Pharmacia (1989-2004) and Amgen (2004-2014). John joined Amgen in late 2004 to build Amgen’s Global Epidemiology group and retired from Amgen in late 2014 as Executive Director and oncology therapeutic area head.
He is a former President of the American College of Epidemiology (2006-2007) and the author/co-author of numerous peer-reviewed publications and book chapters in pharmacoepidemiology, bioethics, and occupational/environmental epidemiology. He holds or has held committee leadership positions in the American College of Epidemiology (Admissions, Nominations, & Publication) and the Society for Epidemiologic Research (Awards). John has been an associate editor for the journal Environmental Health Perspectives and is currently an associate editor for Annals of Epidemiology. He has held adjunct professorships at the University of Massachusetts at Amherst and at the Arnold School of Public Health at the University of South Carolina.
Noel S. Weiss has been a faculty member at the University of Washington and at the Fred Hutchinson Cancer Research Center since 1973. At the Center, he has investigated the epidemiology of gynecologic and other forms of cancer, and from 1985-99 was the recipient of an Outstanding Investigator Award from the National Cancer Institute. Dr. Weiss has also worked extensively in the areas of clinical epidemiology and epidemiologic methods. At the present time, he has authored or co-authored over 600 publications, including the books Clinical Epidemiology: The Study of the Outcome of Illness (Third Edition), Epidemiologic Methods: Studying the Occurrence of Illness (Second Edition), and Exercises in Epidemiology.
Til Stürmer is professor, head of the Pharmacoepidemiology Program, and director of the Center for Pharmacoepidemiology in the Department of Epidemiology at University of North Carolina Gillings School of Public Health.
Til is an internist/epidemiologist with over 20 years of experience of analyzing beneficial and harmful effects of medications using nonexperimental designs. Over the last 10 years, he has evaluated state of the art nonexperimental CER methods and developed new ones funded through an ongoing R01 on “Propensity scores and preventive drug use in the elderly” (AG023178).
Currently, Til is assessing the value of two increasingly used analytic strategies to control for confounding in nonexperimental research: propensity scores and disease risk scores. Propensity score techniques are increasingly used and Til’s work has demonstrated some advantages over multivariable outcome models when used to define comparable study populations.
Based on prior work on correction for measurement error, Til has developed a combination of propensity scores and regression calibration to control for unobserved confounders using data from an external validation study. He has also proposed and evaluated another method to reduce bias when estimating treatment effects due to unmeasured frailty leading physicians to override usual treatment decisions in patients that are very sick (frail, i.e., close to death) by excluding various proportions of patients treated contrary to prediction. As a sensitivity analysis this method can help to quantify and reduce the effect of unmeasured confounding on treatment effect estimates. Along the same line, he has recently published a model predicting frailty based on healthcare claims data.
Til is visiting professor at Department of Clinical Epidemiology, Aarhus University.
Jenny Lund is an Assistant Professor in the Department of Epidemiology at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill (UNC), as well as a faculty member of UNC’s Center for Pharmacoepidemiology and the Lineberger Comprehensive Cancer Center. Through her training, Jenny has developed a broad set of analytic tools, including focused training in health services research and advanced epidemiologic methods and their application to study the utilization and impact of cancer therapies in older patient populations.
She has also amassed vast experience in working with large administrative databases in a variety of disease settings both in the United States and Denmark. Her primary research interests address health-related issues relevant to older cancer patients, including the role of multimorbidity, disability, and frailty in cancer treatment selection and outcomes, the effectiveness and safety of cancer treatment options, and the quality of care delivered. The ultimate goal of her research program is to improve the delivery of medical care and the quality of life for older cancer patients.
Jenny is visiting scientist at Department of Clinical Epidemiology, Aarhus University.
Olaf Dekkers studied medicine and was trained in internal medicine and endocrinology at the Free University in Amsterdam, The Netherlands. Besides medicine, he studied philosophy and graduated on the ‘truth definition according to Frege’. He was trained in epidemiology at the London School of Hygiene and Tropical Medicine.
Olaf Dekkers is currently employed at the departments of Endocrinology and Clinical Epidemiology at the Leiden University Medical Center, The Netherlands. His main research topics are epidemiology of endocrine diseases, meta-analysis, and methodology of research. He works in close collaboration with the Institute of Social and Preventive Medicine in Bern, Switzerland and with the Department of Clinical Epidemiology in Aarhus, Denmark.
Olaf is adjunct professor at Department of Clinical Epidemiology, Aarhus University.